Jump to content

ORCID bibliography before 2021

From Medico-Pharmaceutical Law Universe (by Lumen SI)
Revision as of 00:13, 12 November 2026 by Valentin (talk | contribs) (Document public pre-2021 research with English descriptions and evidence levels)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

This annotated selection was checked against public ORCID work records for Viktoriia Shapovalova, Valerii Shapovalov and Valentyn Shapovalov. It gives English-readable descriptions of research before 2021.

Evidence level: bibliographic metadata. The descriptions identify topics from recorded titles and citations; they do not claim that an abstract or full text was examined for every entry. The presence of a work on a person's ORCID record is not used to reconstruct a missing author list or prove sole authorship. English renderings marked “editorial translation” are reading aids, not assertions that English editions existed. Where an English title was already recorded, its language has been retained, with capitalization regularized for readability.

For more detailed, publisher-grounded descriptions, see Research before 2021. Early records from 1982 and 1984 remain documented in History and research foundations.

1989: Biologically active substances in hydrazide derivatives of succinic heterylamides

A medicinal-chemistry study of hydrazide derivatives of succinic heterylamides. The indexed record connects the early programme to compound-based pharmaceutical research; no efficacy conclusion is inferred here.

Source: Individual public ORCID work record; DOI supplied by the record.

The title places expert preparation within the legal organization of pharmacy, documenting a legal-professional education topic in the 1990s.

Source: Individual public ORCID work record.

A 656-page reference work recorded in Kharkiv, published by Torsing. Its subject bridges legal pharmacy and forensic pharmacy; the ORCID entry does not supply a complete author list.

Source: Individual public ORCID work record.

2000: Evidence-based pharmacy as an element of improving medicine quality (editorial English translation)

A conference contribution whose title explicitly links evidence-based pharmacy to medicine quality, documenting that vocabulary in the 2000 record.

Source: Individual public ORCID work record.

2001: WHO recommendations on registration of medicines of different nomenclature/legal groups (editorial English translation)

A conference abstract concerning WHO recommendations and the registration of medicines across nomenclature/legal categories. This is a historical research topic, not current regulatory guidance.

Source: Individual public ORCID work record.

An article on the relationship between pharmaceutical law, morality and pharmacist–physician–patient relations. The title documents an ethical dimension to the legal research programme.

Source: Individual public ORCID work record.

A journal article concerning the organizational and legal control/authorization system for non-prescription medicines in Ukraine.

Source: Individual public ORCID work record.

2007: Safe use of medicines from the perspective of evidence-based pharmacy (editorial English translation)

A conference abstract on medicine safety viewed through evidence-based pharmacy. Bibliographic evidence only, not an assessment of particular treatments.

Source: Individual public ORCID work record.

2009: From police chemistry to forensic chemical-pharmaceutical expertise; from forensic pharmacy to pharmaceutical law (editorial English translation)

A historical account tracing the department’s subject development from police chemistry and forensic chemical-pharmaceutical expertise towards forensic pharmacy and pharmaceutical law.

Source: Individual public ORCID work record.

2011: Legislation in pharmacy, forensic pharmacy and evidence-based pharmacy : Study book

A 160-page Kharkiv study book bringing pharmacy legislation, forensic pharmacy and evidence-based pharmacy together in a teaching resource.

Source: Individual public ORCID work record.

2013: The Council of Europe convention against counterfeit medical products and similar crimes as a source for developing forensic pharmacy (editorial English translation)

A historical article connecting the Council of Europe convention on counterfeit medical products and related crimes to the development of forensic pharmacy.

Source: Individual public ORCID work record.

2013: Forensic pharmacy: information technology for controlling psychoactive and potentially hazardous substances in retail pharmacy networks (editorial English translation)

An article on information technology for monitoring psychoactive and potentially hazardous substances in retail pharmacy networks.

Source: Individual public ORCID work record.

2014: Forensic-pharmaceutical study of loss-making rural communal pharmacies from a pharmaceutical-law perspective (editorial English translation)

An article on financial sustainability risks in rural communal pharmacies, bringing medicine access and organizational viability into the legal-pharmaceutical field.

Source: Individual public ORCID work record.

An article on organizational and legal implementation of WHO recommendations in chronic-pain pharmaceutical care.

Source: Individual public ORCID work record.

2016: Organization of medicine circulation in the USA (FDA) from a pharmaceutical-law perspective (editorial English translation)

A comparative regulatory contribution on medicine circulation and the US FDA from a pharmaceutical-law perspective.

Source: Individual public ORCID work record.

2017: Content analysis of pharmacies in Ukraine where extemporaneous medicines are manufactured

A study of pharmacies manufacturing extemporaneous medicines, extending the programme to the organization of pharmacy compounding and its availability.

Source: Individual public ORCID work record; DOI supplied by the record.

2018: Research of the medicines’ control regime based on pharmaceutical law

A conference contribution on medicine control regimes viewed through pharmaceutical law.

Source: Individual public ORCID work record.

2018: Forensic and pharmaceutical approaches to study the problem of availability of drugs’ circulation for HIV/AIDS patients based on pharmaceutical law

A study framing HIV/AIDS medicine access as an organizational, forensic-pharmaceutical and pharmaceutical-law problem. Metadata identifies the topic, not a clinical efficacy result.

Source: Individual public ORCID work record; DOI supplied by the record.

A study addressing legal and organizational access to medicines for cancer patients. ORCID supplies journal, volume and pagination; no patient outcome claim is inferred.

Source: Individual public ORCID work record.

2019: Processing of the control regime of medicines for pharmacotherapy of chronic pain syndrome in the field of palliative aid

A study of regulatory control regimes for medicines used in chronic pain and palliative care, connecting pharmaceutical law to access and medicine management.

Source: Individual public ORCID work record; DOI supplied by the record.

2020: Coronavirus Disease Pandemia 2019: Growth of Epidemic Dangers

A 2020 contribution on emerging COVID-19 epidemic dangers, showing the transition into pandemic-era public-health research. Its historical discussion should not substitute for current treatment guidance.

Source: Individual public ORCID work record; DOI supplied by the record.

The 2020 COVID-19 entry has also been checked against the publisher abstract and date; a fuller description is included in Research before 2021.

Date and attribution checks

One boundary case illustrates why online and issue dates should be distinguished: Forensic Pharmacy: Some Risk Factors in the Formation of Addictive Health Disorders was published online on 22 December 2020 but appears in the 2021 volume 5, issue 1, pp. 54–59. The publisher record resolves that distinction. It is not silently assigned to a single year here. Its correlational analysis should not be treated as causal proof. A date-like DOI component is not a substitute for a verified publication date.

These are selected milestones, not a complete publication count. Duplicate imports and translations should not be counted as independent studies without checking the underlying works. Historical legal and medicine-control discussions are not current practice guidance. See People and attribution and Research network.